Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bell

Showing results (991-1000 of 1,019) with videos related to

Pageof 102
Sort By:
International Journal of Systematic and Evolutionary Microbiology|August 1, 2020
Division of the genus <i>Chryseobacterium:</i> Observation of discontinuities in amino acid identity values, a possible consequence of major extinction events, guides transfer of nine species to the genus <i>Epilithonimonas</i>, eleven species to the genus <i>Kaistella</i>, and three species to the genus <i>Halpernia</i> gen. nov., with description of <i>Kaistella daneshvariae</i> sp. nov. and <i>Epilithonimonas vandammei</i> sp. nov. derived from clinical specimensAinsley C Nicholson, Christopher A Gulvik, Anne M Whitney, et al.
Lancet (London, England)|December 7, 2010
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trialGareth J Morgan, Faith E Davies, Walter M Gregory, et al.
Physical Review Letters|November 24, 2011
Continuous improvement of H-mode discharge performance with progressively increasing lithium coatings in the National Spherical Torus ExperimentR Maingi, S M Kaye, C H Skinner, et al.
Nature Communications|May 13, 2025
ATP functions as a pathogen-associated molecular pattern to activate the E3 ubiquitin ligase RNF213Juraj Ahel, Arda Balci, Victoria Faas, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|October 8, 2008
Genomic regions influencing gene expression of the HMW glutenins in wheatEric W Storlie, Robert J Ihry, Leslie M Baehr, et al.
Blood|June 10, 2011
Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantationGareth J Morgan, Faith E Davies, Walter M Gregory, et al.
Blood|September 23, 2008
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotypingDavid C Johnson, Sophie Corthals, Christine Ramos, et al.
Cell|August 28, 2025
A split-site E3 ligase mechanism enables ZNFX1 to ubiquitinate and cluster single-stranded RNA into ubiquitin-coated nucleoprotein particlesDaniel B Grabarczyk, Eric J Aird, Vanessa Reznikow, et al.
The Lancet. Oncology|July 21, 2011
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trialGareth J Morgan, J Anthony Child, Walter M Gregory, et al.
The Lancet. Respiratory Medicine|May 20, 2017
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised studyJohn H Beigel, Pablo Tebas, Marie-Carmelle Elie-Turenne, et al.
Pageof 102

Showing results (991-1000 of 1,019) with videos related to

Sort By:
Pageof 102
International Journal of Systematic and Evolutionary Microbiology|August 1, 2020
Division of the genus <i>Chryseobacterium:</i> Observation of discontinuities in amino acid identity values, a possible consequence of major extinction events, guides transfer of nine species to the genus <i>Epilithonimonas</i>, eleven species to the genus <i>Kaistella</i>, and three species to the genus <i>Halpernia</i> gen. nov., with description of <i>Kaistella daneshvariae</i> sp. nov. and <i>Epilithonimonas vandammei</i> sp. nov. derived from clinical specimensAinsley C Nicholson, Christopher A Gulvik, Anne M Whitney, et al.
Lancet (London, England)|December 7, 2010
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trialGareth J Morgan, Faith E Davies, Walter M Gregory, et al.
Physical Review Letters|November 24, 2011
Continuous improvement of H-mode discharge performance with progressively increasing lithium coatings in the National Spherical Torus ExperimentR Maingi, S M Kaye, C H Skinner, et al.
Nature Communications|May 13, 2025
ATP functions as a pathogen-associated molecular pattern to activate the E3 ubiquitin ligase RNF213Juraj Ahel, Arda Balci, Victoria Faas, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|October 8, 2008
Genomic regions influencing gene expression of the HMW glutenins in wheatEric W Storlie, Robert J Ihry, Leslie M Baehr, et al.
Blood|June 10, 2011
Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantationGareth J Morgan, Faith E Davies, Walter M Gregory, et al.
Blood|September 23, 2008
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotypingDavid C Johnson, Sophie Corthals, Christine Ramos, et al.
Cell|August 28, 2025
A split-site E3 ligase mechanism enables ZNFX1 to ubiquitinate and cluster single-stranded RNA into ubiquitin-coated nucleoprotein particlesDaniel B Grabarczyk, Eric J Aird, Vanessa Reznikow, et al.
The Lancet. Oncology|July 21, 2011
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trialGareth J Morgan, J Anthony Child, Walter M Gregory, et al.
The Lancet. Respiratory Medicine|May 20, 2017
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised studyJohn H Beigel, Pablo Tebas, Marie-Carmelle Elie-Turenne, et al.
Pageof 102